Karyopharm reports topline Phase 3 trial results in endometrial cancer
Kaigene and Taisho enter exclusive KG006 licensing agreement in Japan
Pfizer reports positive Phase 3 results for LITFULO in nonsegmental vitiligo
Octapharma to build USD1.5bn critical care manufacturing facility in Rock Hill, SC
Ractigen Therapeutics closes over USD31m financing for project advancement
10x Genomics and Lausanne University Hospital to collaborate on cancer care research
European Commission approves RINVOQ for severe alopecia areata
AbCellera and Vertex agree collaboration to develop multispecific T-cell engagers
Incyte's Opzelura approved in European Union for moderate atopic dermatitis
RTW Biotech portfolio company Yarrow Bioscience completes merger
Hemogenyx partners with Lithuanian cancer centre on HG-CT-1 research and clinical programme
Evinova and Merck KGaA partner to accelerate AI-driven clinical development
WuXi Biologics gains FTSE4Good recognition for sixth consecutive year
Lantern Pharma advances EMA-cleared Phase 1b/2 bladder cancer trial for LP-184